浙江永宁药业股份有限公司

Zhejiang Yongning Pharmaceutical Co. Ltd.

Country: CN CDE+DMF VERY_HIGH

🇨🇳 CDE

31

31 products shown

🇺🇸 DMF

2

2 products shown

🇪🇺 CEP

0

0 products shown

Total

33

registrations

🇨🇳 CDE 注册 (31)

Product CAS Status Reg Number
Amikacin

阿米卡星

37517-28-5 Class A Y20190003464
Amikacin Sulfate

硫酸阿米卡星

39831-55-5 Class A Y20190003463
Azithromycin

阿奇霉素

83905-01-5 Class A Y20190003427
Aztreonam

氨曲南

78110-38-0 Class A Y20190001217
Candesartan Cilexetil

坎地沙坦酯

139481-59-7 Class A Y20190003641
Cefamandole Nafate

头孢孟多酯钠

34444-01-4 Class A Y20190003430
Cefdinir

头孢地尼

91832-40-5 Class A Y20190007376
Cefepime

头孢吡肟

88040-23-7 Class A Y20190001761
Cefetamet

盐酸头孢他美酯

65052-63-3 Class A Y20190003438
Cefixime

头孢克肟

79350-37-1 Class A Y20190001903
Cefodizime Sodium

头孢地嗪钠

69739-16-8 Class A Y20190003459
Cefonicid Sodium

头孢尼西钠

61270-58-4 Class A Y20190002622
Cefoperazone Sodium

头孢哌酮钠等29个原料药

62893-19-0 Class A Y20190006047
Cefotaxime Sodium

头孢噻肟钠

63527-52-6 Class A Y20190003613
Cefotiam

盐酸头孢替安

61622-34-2 Class A Y20190007519
Cefpirome Sulfate

硫酸头孢匹罗/碳酸钠

84957-29-9 Class A Y20190002670
Ceftazidime

头孢他啶(注射用)

72558-82-8 Class A Y20190007754
Ceftriaxone Sodium

头孢曲松钠

73384-59-5 Class A Y20190003477
Cefuroxime Sodium

头孢呋辛钠

55268-75-2 Class A Y20190003590
Cephalothin Sodium

头孢噻吩钠

- Class A Y20190003474
Cilostazol

西洛他唑

73963-72-1 Class A Y20190002234
Clarithromycin

克拉霉素

81103-11-9 Class A Y20190001904
Doxofylline

多索茶碱

69975-86-6 Class A Y20220000979
Ganciclovir

更昔洛韦

82410-32-0 Class A Y20190007910
Levocetirizine

盐酸左西替利嗪

130018-77-8 Class A Y20190007284
Ofloxacin

氧氟沙星

82419-36-1 Class A Y20190003476
Sulbactam Sodium

舒巴坦钠

68373-14-8 Class A Y20190006052
Tadalafil

他达拉非

171596-29-5 Class A Y20190021619
Thymopentin

胸腺五肽

69558-55-0 Class A Y20190004816
Topiroxostat

托匹司他

577778-58-6 Class I Y20240000930
Vecuronium Bromide

维库溴铵

86029-43-8 Class A Y20190001218

🇺🇸 DMF 注册 (2)

Product CAS DMF Number Date
3990 Acid, Pharmaceutical Intermediate - - 2004-07-03
Tadalafil

他达拉非

171596-29-5 - 2019-04-11

Source: cde+fda_direct; DMF高置信 | Updated: 2026-04-09 07:23:01